{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T17:38:04Z","timestamp":1781285884682,"version":"3.54.1"},"reference-count":39,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,10]],"date-time":"2024-07-10T00:00:00Z","timestamp":1720569600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81872764"],"award-info":[{"award-number":["81872764"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82273808"],"award-info":[{"award-number":["82273808"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82272654"],"award-info":[{"award-number":["82272654"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Acta Pharmaceutica Sinica B"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.apsb.2024.07.013","type":"journal-article","created":{"date-parts":[[2024,7,14]],"date-time":"2024-07-14T09:59:31Z","timestamp":1720951171000},"page":"467-483","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Natural product mediated mesenchymal\u2013epithelial remodeling by covalently binding ENO1 to degrade m6A modified \u03b2-catenin mRNA"],"prefix":"10.1016","volume":"15","author":[{"given":"Tianyang","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangju","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sisi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengyuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuoqian","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongping","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yahui","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.apsb.2024.07.013_bib1","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1016\/S0140-6736(22)01200-4","article-title":"Hepatocellular carcinoma","volume":"400","author":"Vogel","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.apsb.2024.07.013_bib2","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1002\/hep.30930","article-title":"PDLIM1 inhibits tumor metastasis through activating hippo signaling in hepatocellular carcinoma","volume":"71","author":"Huang","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.apsb.2024.07.013_bib3","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1016\/j.jhep.2016.05.007","article-title":"Role of epithelial to mesenchymal transition in hepatocellular carcinoma","volume":"65","author":"Giannelli","year":"2016","journal-title":"J Hepatol"},{"key":"10.1016\/j.apsb.2024.07.013_bib4","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1002\/cac2.12138","article-title":"EMT-associated microRNAs and their roles in cancer stemness and drug resistance","volume":"41","author":"Pan","year":"2021","journal-title":"Cancer Commun (Lond)"},{"key":"10.1016\/j.apsb.2024.07.013_bib5","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.tcb.2018.12.001","article-title":"EMT transition states during tumor progression and metastasis","volume":"29","author":"Pastushenko","year":"2019","journal-title":"Trends Cel Biol"},{"key":"10.1016\/j.apsb.2024.07.013_bib6","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.trecan.2020.03.011","article-title":"Emerging mechanisms by which EMT programs control stemness","volume":"6","author":"Wilson","year":"2020","journal-title":"Trends Cancer"},{"key":"10.1016\/j.apsb.2024.07.013_bib7","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1093\/annonc\/mdg486","article-title":"The role of the E-cadherin gene (CDH1) in diffuse gastric cancer susceptibility: from the laboratory to clinical practice","volume":"14","author":"Graziano","year":"2003","journal-title":"Ann Oncol"},{"key":"10.1016\/j.apsb.2024.07.013_bib8","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1016\/S0959-8049(00)00158-1","article-title":"The E-cadherin\u2013catenin complex in tumour metastasis: structure, function and regulation","volume":"36","author":"Beavon","year":"2000","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.apsb.2024.07.013_bib9","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.critrevonc.2017.11.010","article-title":"E-cadherin: its dysregulation in carcinogenesis and clinical implications","volume":"121","author":"Wong","year":"2018","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.apsb.2024.07.013_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2020.101697","article-title":"Epigenetic reprogramming of epithelial\u2013mesenchymal transition promotes ferroptosis of head and neck cancer","volume":"37","author":"Lee","year":"2020","journal-title":"Redox Biol"},{"key":"10.1016\/j.apsb.2024.07.013_bib11","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1001\/jamasurg.2020.6155","article-title":"Hereditary diffuse gastric cancer syndrome and the role of CDH1: a review","volume":"156","author":"Gamble","year":"2021","journal-title":"JAMA Surg"},{"key":"10.1016\/j.apsb.2024.07.013_bib12","doi-asserted-by":"crossref","DOI":"10.1111\/cpr.12617","article-title":"Six2 promotes non-small cell lung cancer cell stemness via transcriptionally and epigenetically regulating E-cadherin","volume":"52","author":"Hou","year":"2019","journal-title":"Cell Prolif"},{"key":"10.1016\/j.apsb.2024.07.013_bib13","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.3390\/cells8101118","article-title":"The E-cadherin and N-cadherin switch in epithelial-to-mesenchymal transition: signaling, therapeutic implications, and challenges","volume":"8","author":"Loh","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.apsb.2024.07.013_bib14","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1158\/1541-7786.MCR-18-0637","article-title":"Nuclear E-cadherin acetylation promotes colorectal tumorigenesis via enhancing beta-ccatenin activity","volume":"17","author":"Zhao","year":"2019","journal-title":"Mol Cancer Res"},{"key":"10.1016\/j.apsb.2024.07.013_bib15","doi-asserted-by":"crossref","first-page":"e157","DOI":"10.1038\/oncsis.2015.17","article-title":"An aberrant nuclear localization of E-cadherin is a potent inhibitor of Wnt\/beta-catenin-elicited promotion of the cancer stem cell phenotype","volume":"4","author":"Su","year":"2015","journal-title":"Oncogenesis"},{"key":"10.1016\/j.apsb.2024.07.013_bib16","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2020478118","article-title":"Tumor-suppressor function of Beclin 1 in breast cancer cells requires E-cadherin","volume":"118","author":"Wijshake","year":"2021","journal-title":"Proc Natl Acad Sci U\u00a0S\u00a0A"},{"key":"10.1016\/j.apsb.2024.07.013_bib17","doi-asserted-by":"crossref","first-page":"3981","DOI":"10.7150\/ijbs.63556","article-title":"Enolase 1, a moonlighting protein, as a potential target for cancer treatment","volume":"17","author":"Qiao","year":"2021","journal-title":"Int J Biol Sci"},{"key":"10.1016\/j.apsb.2024.07.013_bib18","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.omto.2021.12.026","article-title":"ENO1 and cancer","volume":"24","author":"Huang","year":"2022","journal-title":"Mol Ther Oncolytics"},{"key":"10.1016\/j.apsb.2024.07.013_bib19","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/1476-4598-13-65","article-title":"Alpha-enolase as a potential cancer prognostic marker promotes cell growth, migration, and invasion in glioma","volume":"13","author":"Song","year":"2014","journal-title":"Mol Cancer"},{"key":"10.1016\/j.apsb.2024.07.013_bib20","doi-asserted-by":"crossref","first-page":"3868","DOI":"10.3390\/ijms19123868","article-title":"The biological significance and regulatory mechanism of c-myc binding protein 1 (MBP-1)","volume":"19","author":"Liu","year":"2018","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.apsb.2024.07.013_bib21","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1038\/s42255-020-00313-3","article-title":"An enolase inhibitor for the targeted treatment of ENO1-deleted cancers","volume":"2","author":"Lin","year":"2020","journal-title":"Nat Metab"},{"key":"10.1016\/j.apsb.2024.07.013_bib22","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1038\/s41589-023-01391-6","article-title":"ENO1 promotes liver carcinogenesis through YAP1-dependent arachidonic acid metabolism","volume":"19","author":"Sun","year":"2023","journal-title":"Nat Chem Biol"},{"key":"10.1016\/j.apsb.2024.07.013_bib23","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/s43018-021-00299-1","article-title":"ENO1 suppresses cancer cell ferroptosis by degrading the mRNA of iron regulatory protein 1","volume":"3","author":"Zhang","year":"2022","journal-title":"Nat Cancer"},{"key":"10.1016\/j.apsb.2024.07.013_bib24","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.molcel.2023.01.006","article-title":"RNA m6A methylation across the transcriptome","volume":"83","author":"Sendinc","year":"2023","journal-title":"Mol Cel"},{"key":"10.1016\/j.apsb.2024.07.013_bib25","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/s41590-022-01398-6","article-title":"YTHDF2 orchestrates tumor-associated macrophage reprogramming and controls antitumor immunity through CD8+ T cells","volume":"24","author":"Ma","year":"2023","journal-title":"Nat Immunol"},{"key":"10.1016\/j.apsb.2024.07.013_bib26","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1186\/s13045-022-01347-8","article-title":"The molecular mechanisms and therapeutic strategies of EMT in tumor progression and metastasis","volume":"15","author":"Huang","year":"2022","journal-title":"J Hematol Oncol"},{"key":"10.1016\/j.apsb.2024.07.013_bib27","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2209563119","article-title":"Targeting breast and pancreatic cancer metastasis using a dual-cadherin antibody","volume":"119","author":"Micalizzi","year":"2022","journal-title":"Proc Natl Acad Sci U\u00a0S\u00a0A"},{"key":"10.1016\/j.apsb.2024.07.013_bib28","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.phytochem.2017.09.016","article-title":"Chrysin: sources, beneficial pharmacological activities, and molecular mechanism of action","volume":"145","author":"Mani","year":"2018","journal-title":"Phytochemistry"},{"key":"10.1016\/j.apsb.2024.07.013_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2019.116797","article-title":"Chrysin: pharmacological and therapeutic properties","volume":"235","author":"Naz","year":"2019","journal-title":"Life Sci"},{"key":"10.1016\/j.apsb.2024.07.013_bib30","doi-asserted-by":"crossref","first-page":"420","DOI":"10.2174\/1389450122666210824141044","article-title":"A comprehensive review on chrysin: emphasis on molecular targets, pharmacological actions and bio-pharmaceutical aspects","volume":"23","author":"Garg","year":"2022","journal-title":"Curr Drug Targets"},{"key":"10.1016\/j.apsb.2024.07.013_bib31","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.apsb.2020.07.011","article-title":"Chrysin serves as a novel inhibitor of DGKalpha\/FAK interaction to suppress the malignancy of esophageal squamous cell carcinoma (ESCC)","volume":"11","author":"Chen","year":"2021","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.apsb.2024.07.013_bib32","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.cbpa.2014.10.021","article-title":"Covalent protein modification: the current landscape of residue-specific electrophiles","volume":"24","author":"Shannon","year":"2015","journal-title":"Curr Opin Chem Biol"},{"key":"10.1016\/j.apsb.2024.07.013_bib33","doi-asserted-by":"crossref","first-page":"2666","DOI":"10.1016\/j.molcel.2022.05.019","article-title":"Riboregulation of enolase 1 activity controls glycolysis and embryonic stem cell differentiation","volume":"82","author":"Huppertz","year":"2022","journal-title":"Mol Cel"},{"key":"10.1016\/j.apsb.2024.07.013_bib34","article-title":"N6-methyladenosine reader YTHDF family in biological processes: structures, roles, and mechanisms","volume":"14","author":"Chen","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.apsb.2024.07.013_bib35","doi-asserted-by":"crossref","first-page":"3816","DOI":"10.1093\/nar\/gkaa048","article-title":"The m6A reader YTHDF1 promotes ovarian cancer progression via augmenting EIF3C translation","volume":"48","author":"Liu","year":"2020","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.apsb.2024.07.013_bib36","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1186\/s12943-020-01267-6","article-title":"YTHDF2 mediates the mRNA degradation of the tumor suppressors to induce AKT phosphorylation in N6-methyladenosine-dependent way in prostate cancer","volume":"19","author":"Li","year":"2020","journal-title":"Mol Cancer"},{"key":"10.1016\/j.apsb.2024.07.013_bib37","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/cr.2017.15","article-title":"YTHDF3 facilitates translation and decay of N6-methyladenosine-modified RNA","volume":"27","author":"Shi","year":"2017","journal-title":"Cell Res"},{"key":"10.1016\/j.apsb.2024.07.013_bib38","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.molcel.2016.01.012","article-title":"Nuclear m6A reader YTHDC1 regulates mRNA splicing","volume":"61","author":"Xiao","year":"2016","journal-title":"Mol Cel"},{"key":"10.1016\/j.apsb.2024.07.013_bib39","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1002\/adsc.201000206","article-title":"Stabilized copper(I) oxide nanoparticles catalyze azide-alkyne click reactions in water","volume":"352","author":"Zhang","year":"2010","journal-title":"Adv Synth Catal"}],"container-title":["Acta Pharmaceutica Sinica B"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211383524002879?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211383524002879?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T22:04:37Z","timestamp":1739916277000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211383524002879"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["S2211383524002879"],"URL":"https:\/\/doi.org\/10.1016\/j.apsb.2024.07.013","relation":{},"ISSN":["2211-3835"],"issn-type":[{"value":"2211-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Natural product mediated mesenchymal\u2013epithelial remodeling by covalently binding ENO1 to degrade m6A modified \u03b2-catenin mRNA","name":"articletitle","label":"Article Title"},{"value":"Acta Pharmaceutica Sinica B","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.apsb.2024.07.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V. on behalf of Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences.","name":"copyright","label":"Copyright"}]}}